These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26407281)

  • 1. Intussusception Cases Among Children Admitted to Referral Hospitals in Kenya, 2002-2013: Implications for Monitoring Postlicensure Safety of Rotavirus Vaccines in Africa.
    Omore R; Osawa F; Musia J; Rha B; Ismail A; Kiulia NM; Moke F; Vulule J; Wainaina AM; Tole J; Machoki SM; Nuorti JP; Breiman RF; Parashar UD; Montgomery JM; Tate JE
    J Pediatric Infect Dis Soc; 2016 Dec; 5(4):465-469. PubMed ID: 26407281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparing for safety monitoring after rotavirus vaccine implementation: a retrospective review of intussusception cases among children at a large teaching hospital in Rwanda, 2009-2012.
    Ngendahayo E; Bonane A; Ntakiyiruta G; Munyanshongore A; Muganga N; Bikoroti J; Mwenda JM; Tate JE; Ngabo F
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S99-S103. PubMed ID: 24343624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop on intussusception in African countries--meeting report.
    Steele AD; Patel M; Cunliffe NA; Bresee JS; Borgstein E; Parashar UD
    Vaccine; 2012 Apr; 30 Suppl 1():A185-9. PubMed ID: 22520130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.
    Lloyd-Johnsen C; Justice F; Donath S; Bines JE
    Vaccine; 2012 Apr; 30 Suppl 1():A190-5. PubMed ID: 22520131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries.
    Burnett E; Van Trang N; Rayamajhi A; Yousafzai MT; Satter SM; Anh DD; Thapa A; Qazi SH; Heffelfinger JD; Hung PH; Rayamajhi AK; Saddal N; Flora MS; Canh TM; Ali SA; Gurley ES; Tate JE; Yen C; Parashar UD
    Vaccine; 2018 Nov; 36(50):7593-7598. PubMed ID: 30414781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of childhood intussusception in Bangladesh: Findings from an active national hospital based surveillance system, 2012-2016.
    Satter SM; Aliabadi N; Yen C; Gastañaduy PA; Ahmed M; Mamun A; Islam K; Flora MS; Rahman M; Zaman K; Rahman M; Heffelfinger JD; Luby SP; Gurley ES; Parashar UD
    Vaccine; 2018 Dec; 36(51):7805-7810. PubMed ID: 28941622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
    Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
    Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk.
    Buttery JP; Standish J; Bines JE
    Pediatr Infect Dis J; 2014 Jul; 33(7):772-3. PubMed ID: 24732449
    [No Abstract]   [Full Text] [Related]  

  • 11. Intussusception Rate Among Under-Five-Children Before Introduction of Rotavirus Vaccine in North India.
    Gupta M; Kanojia R; Singha R; Tripathy JP; Mahajan K; Saxena A; Bansal A; Muralidharan J; Kumar R
    J Trop Pediatr; 2018 Aug; 64(4):326-335. PubMed ID: 29040742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal.
    Rayamajhi A; Thapa A; Kumar M; Yen C; Tate JE; Parashar UD; Rayamajhi AK
    Vaccine; 2018 Dec; 36(51):7836-7840. PubMed ID: 29169894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.
    Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T
    Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.
    Chang HG; Smith PF; Ackelsberg J; Morse DL; Glass RI
    Pediatrics; 2001 Jul; 108(1):54-60. PubMed ID: 11433054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intussusception hospitalizations before rotavirus vaccine introduction: Retrospective data from two referral hospitals in Tamil Nadu, India.
    Srinivasan R; Girish Kumar CP; Naaraayan SA; Jehangir S; Thangaraj JWV; Venkatasubramanian S; Kang G
    Vaccine; 2018 Dec; 36(51):7820-7825. PubMed ID: 29199044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact.
    Mwenda JM; Tate JE; Steele AD; Parashar UD
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S1-5. PubMed ID: 24343605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.
    Ratu FT; Reyburn R; Tuivaga E; Tuiketei A; Jenkins K; Mulholland K; Jenney A; Russell F
    Sci Rep; 2018 Jul; 8(1):11194. PubMed ID: 30046133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013.
    Liu N; Yen C; Huang T; Cui P; Tate JE; Jiang B; Parashar UD; Duan ZJ
    Vaccine; 2018 Dec; 36(51):7862-7867. PubMed ID: 29439864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.